OBJECTIVE: To study the clinical features of neuroblastoma (NB) and the factors influencing survival rate. METHODS: A total of 44 children with NB who were admitted from April 2016 to February 2020 were enrolled as research subjects. A retrospective analysis was performed on their medical data and follow-up data. RESULTS: The common clinical symptoms of these 44 children were fever (10/44, 23%), mass (9/44, 20%), abdominal pain (8/44, 18%), cough (7/44, 16%), pale complexion (3/44, 7%), claudication (2/44, 5%), and abnormal activity (2/44, 5%). According to the INSS stage, 2 children (4%) had stage I NB, 5 children (11%) had stage II NB, 5 children (11%) had stage III NB, and 32 children (73%) had stage IV NB. The mean follow-up time was (15.3±1.5) months, with a recurrence rate of 20% and an overall survival rate of 82%. Among the 44 children, 29 (66%) achieved event-free survival and 7 (16%) had survival with tumor. The univariate analysis showed that a pathological type of NB and an increase in serum neuron-specific enolase (NSE) decreased the overall survival rate of children with NB (P<0.05). CONCLUSIONS: The clinical symptoms of children with NB are not specific at the first visit. Fever, abdominal pain, and mass are common symptoms, and there is a high proportion of children in the advanced stage. The pathological type of NB and an increase in serum NSE may be associated with a reduction in the overall survival rate of children with NB.
OBJECTIVE: To study the clinical features of neuroblastoma (NB) and the factors influencing survival rate. METHODS: A total of 44 children with NB who were admitted from April 2016 to February 2020 were enrolled as research subjects. A retrospective analysis was performed on their medical data and follow-up data. RESULTS: The common clinical symptoms of these 44 children were fever (10/44, 23%), mass (9/44, 20%), abdominal pain (8/44, 18%), cough (7/44, 16%), pale complexion (3/44, 7%), claudication (2/44, 5%), and abnormal activity (2/44, 5%). According to the INSS stage, 2 children (4%) had stage I NB, 5 children (11%) had stage II NB, 5 children (11%) had stage III NB, and 32 children (73%) had stage IV NB. The mean follow-up time was (15.3±1.5) months, with a recurrence rate of 20% and an overall survival rate of 82%. Among the 44 children, 29 (66%) achieved event-free survival and 7 (16%) had survival with tumor. The univariate analysis showed that a pathological type of NB and an increase in serum neuron-specific enolase (NSE) decreased the overall survival rate of children with NB (P<0.05). CONCLUSIONS: The clinical symptoms of children with NB are not specific at the first visit. Fever, abdominal pain, and mass are common symptoms, and there is a high proportion of children in the advanced stage. The pathological type of NB and an increase in serum NSE may be associated with a reduction in the overall survival rate of children with NB.
Authors: V Castel; P García-Miguel; A Cañete; C Melero; A Navajas; J I Ruíz-Jiménez; S Navarro; M D Badal Journal: Eur J Cancer Date: 1999-04 Impact factor: 9.162
Authors: Holly J Meany; Wendy B London; Peter F Ambros; Katherine K Matthay; Tom Monclair; Thorsten Simon; Alberto Garaventa; Frank Berthold; Akira Nakagawara; Susan L Cohn; Andrew D J Pearson; Julie R Park Journal: Pediatr Blood Cancer Date: 2014-07-07 Impact factor: 3.167
Authors: S Suita; T Tajiri; Y Sera; H Takamatsu; H Mizote; H Ohgami; N Kurosaki; T Hara; J Okamura; S Miyazaki; T Sugimoto; K Kawakami; M Tsuneyoshi; H Tasaka; H Yano; H Akiyama; K Ikeda Journal: Eur J Pediatr Surg Date: 2000-12 Impact factor: 2.191
Authors: Cynthia S Kretschmar; Morris Kletzel; Kevin Murray; Paul Thorner; Vijay Joshi; Robert Marcus; E Ide Smith; Wendy B London; Robert Castleberry Journal: J Clin Oncol Date: 2004-10-15 Impact factor: 44.544
Authors: J H Schulte; S Schulte; L C Heukamp; K Astrahantseff; H Stephan; M Fischer; A Schramm; A Eggert Journal: Klin Padiatr Date: 2013-10-28 Impact factor: 1.349
Authors: T Iehara; H Hosoi; K Akazawa; Y Matsumoto; K Yamamoto; S Suita; T Tajiri; T Kusafuka; E Hiyama; M Kaneko; F Sasaki; T Sugimoto; T Sawada Journal: Br J Cancer Date: 2006-05-22 Impact factor: 7.640
Authors: Wei-Ling Liang; Xiao-Fan Ye; Gong Zhong; Jian-Jun Chen; Kang-Lin Dai; Ka Leung Daniel Cheuk; Shu Mo; Bo-Shen Wang; Chun-Yu Li; Xuan-Zhu Jiang; Zhi-Yuan Xu; Li Zhou; Irene Chan; Jian-Liang Chen; Patrick Chu; Pui Wah Pamela Lee; Chi Fung Godfrey Chan Journal: Zhongguo Dang Dai Er Ke Za Zhi Date: 2022-07-15